1. Home
  2. About Axol

About Axol Bioscience

We generate cells derived from human induced pluripotent stem cells for more reliable, more robust, and more human models of disease.

hiPSCs and the Axol story

Research needs physiologically relevant, reliable, and scalable in vitro models for screening, safety, and discovery. We deliver these models through cells derived from human induced pluripotent stem cells (hiPSCs).

Over the last decade, development groups here at Axol have gained an international reputation for our production and characterization of ‘excitable’ cells. These include CiPA-validated cardiomyocytes, widely used in drug safety screening, and neural stem cells from patients with neurological conditions including Alzheimer’s disease and Parkinson’s disease, both primary areas for pharmaceutical development. We also generate astrocytes, microglia, and motor neurons.

Axol Bioscience was founded in 2013 by Jonathan Milner and Yichen Shi. Since our merger with Censo Biotechnologies in 2021 we have evolved to offer custom in-house laboratory services to support biotech and pharma and a read-to-sequence library of cells and supporting media and reagents.

Axol operates under ISO 9001:2015 certification and has an open culture of collaboration and we endeavor to support the future of human research.

For all corporate enquiries, contact info@axolbio.com

About us timeline

Quality Policy

Axol Bioscience is committed to being a trusted supplier of human iPSC-derived cells, media products, and related contract services for life science discovery. Our quality policy defines our dedication to performance and quality standards that solidify Axol as a supplier of choice in the iPSC market.

A culture of Quality

With the rapid uptake of iPSC-based products and technologies for use in
drug development R&D and screening, there is a growing call from users for
better reproducibility and consistency in these increasingly critical tools.

We have ISO 9001:2015 certification at our manufacturing site in Edinburgh, Scotland.

The three guiding principles of our quality process are:

• Commitment to a quality culture
• Commitment to a customer focus
• Commitment to regulatory compliance

Leadership in Quality

  • Maintain quality culture through line management and by personal example in work practices
  • Ensure the availability of resources to implement, maintain, and review quality policy and standards
  • Oversee regular audits of both objectives and practices within the QMS system

Always comply with all relevant standards, regulations and industry codes of practice.

Customer Focus

  • Function at all times with work practices that embody the 6 value pillars of the Axol organisation; Performance, Honesty, Transparency, Accountability, Diversity and Inclusion
  • Adhere to QMS system that conforms to ISO standards and tracks quality metrics and review that system on a regular basis
  • Provide adequate training for staff to always follow established protocols and procedures
  • Encourages collaboration among scientific talent to ensure best practices are executed and reviewed regularly
  • Conduct a regular review of customer feedback to ensure that the quality system objectives reflect customer expectations

Regulatory Compliance

  • Always comply with all relevant standards, regulations and industry codes of practice

Statement of Use

Download the Axol Statement of Use

We, Axol Bioscience Ltd, hereby certify that any human material or products provided by this company, have been removed or collected with the donor/s prior consent and are intended for research use only. No payment whatsoever has been received by these donors.

In addition, we hereby declare that Censo Biotechnologies Ltd (trading as Axol Bioscience) complies with all relevant standards, regulations and industry codes of practice.

How can we help?

White Paper